Literature DB >> 35295360

Analysis of Pregnant Women Recovered From Antenatal SARS-CoV-2 Infection: An Observational Study.

Mousumi D Ghosh1, Mamta R Datta1, Vinita Singh1, Anisha Choudhary1.   

Abstract

Background and objective The global health care system is facing the challenge of diagnosing and treating the ongoing coronavirus disease 2019 (COVID-19) pandemic. Pregnant women belong to a vulnerable group, and the effect of the virus on the mother and fetus is not well established. The aim of the study was to understand the maternal and fetal outcomes after recovery from antenatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods  This was a retrospective observational study conducted at Tata Main Hospital, Jamshedpur, India. It included all COVID-19-negative pregnant women who had delivered between 1st January 2021 and 31st August 2021 and had tested positive in the antenatal period (by reverse transcription-polymerase chain reaction (RT-PCR)), the details of which are available in the hospital database. Results A total of 53 women were included in our study who had tested positive in the antenatal period and had turned negative during delivery. Out of the 53 women, 5.7% were infected in the first trimester, 34% in the second trimester, and 60.3% were positive in the third trimester. We found an asymptomatic subgroup in 52.8% of women and mild symptoms in 41.5% of women. Two women were admitted in their antenatal period with moderate COVID-19 disease and one with severe. Preterm births between 34 weeks and 37 weeks were seen in 26.4% of women. Vaginal delivery accounted for 30.2% of cases. The most common indications for cesarean section were fetal distress (17%), previous cesarean section (17%), and unwillingness for vaginal delivery. Out of the 53 pregnant women included in the study, acute respiratory distress syndrome (ARDS) was seen in two women- one diagnosed intraoperatively during cesarean section and the other was diagnosed on the first postoperative day. Conclusion The study showed that pregnant women infected with SARS-CoV-2 usually have no/mild symptoms, and they recover well and have favorable maternal and neonatal outcomes. However, perinatal vigilance is advisable in these cases, as there is a risk of developing respiratory morbidity.
Copyright © 2022, Ghosh et al.

Entities:  

Keywords:  antenatal; covid-19; outcome; pregnancy; recovery; sars-cov-2

Year:  2022        PMID: 35295360      PMCID: PMC8917808          DOI: 10.7759/cureus.22094

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

Review 1.  COVID-19 in pregnancy and the puerperium: A review for emergency physicians.

Authors:  Marina N Boushra; Alex Koyfman; Brit Long
Journal:  Am J Emerg Med       Date:  2020-11-02       Impact factor: 2.469

2.  Impact of COVID-19 on Pregnancy.

Authors:  Chiu-Lin Wang; Yi-Yin Liu; Chin-Hu Wu; Chun-Yu Wang; Chun-Hung Wang; Cheng-Yu Long
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

3.  The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis.

Authors:  Fares Qeadan; Nana A Mensah; Benjamin Tingey; Joseph B Stanford
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-16       Impact factor: 3.007

4.  Doppler assessment of the fetus in pregnant women recovered from COVID-19.

Authors:  Ali T Anuk; Atakan Tanacan; Fatma D Y Yetiskin; Gul N Buyuk; Selvi A Senel; Huseyin L Keskin; Ozlem Moraloglu; Dilek Uygur
Journal:  J Obstet Gynaecol Res       Date:  2021-03-01       Impact factor: 1.697

5.  Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study.

Authors:  José Villar; Shabina Ariff; Robert B Gunier; Ramachandran Thiruvengadam; Stephen Rauch; Alexey Kholin; Paola Roggero; Federico Prefumo; Marynéa Silva do Vale; Jorge Arturo Cardona-Perez; Nerea Maiz; Irene Cetin; Valeria Savasi; Philippe Deruelle; Sarah Rae Easter; Joanna Sichitiu; Constanza P Soto Conti; Ernawati Ernawati; Mohak Mhatre; Jagjit Singh Teji; Becky Liu; Carola Capelli; Manuela Oberto; Laura Salazar; Michael G Gravett; Paolo Ivo Cavoretto; Vincent Bizor Nachinab; Hadiza Galadanci; Daniel Oros; Adejumoke Idowu Ayede; Loïc Sentilhes; Babagana Bako; Mónica Savorani; Hellas Cena; Perla K García-May; Saturday Etuk; Roberto Casale; Sherief Abd-Elsalam; Satoru Ikenoue; Muhammad Baffah Aminu; Carmen Vecciarelli; Eduardo A Duro; Mustapha Ado Usman; Yetunde John-Akinola; Ricardo Nieto; Enrico Ferrazi; Zulfiqar A Bhutta; Ana Langer; Stephen H Kennedy; Aris T Papageorghiou
Journal:  JAMA Pediatr       Date:  2021-08-01       Impact factor: 16.193

6.  Treatment With Remdesivir in Two Pregnant Patients With COVID-19 Pneumonia.

Authors:  Vinita Singh; Anisha Choudhary
Journal:  Cureus       Date:  2021-05-12

Review 7.  Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice.

Authors:  Marta López; Anna Gonce; Eva Meler; Ana Plaza; Sandra Hernández; Raigam J Martinez-Portilla; Teresa Cobo; Felipe García; Maria Dolores Gómez Roig; Eduard Gratacós; Montse Palacio; Francesc Figueras
Journal:  Fetal Diagn Ther       Date:  2020-06-12       Impact factor: 2.587

8.  No obviously adverse pregnancy complications and outcomes of the recovered pregnant women from COVID-19.

Authors:  Cuifang Fan; Yuping Guo; Peng Qu; Suqing Wang; Ming Wang; Jingping Yuan; Chunyan Li; Likun Gao; Yiming Pang; Zhiwen Li; Bin Wang
Journal:  Reprod Toxicol       Date:  2020-11-26       Impact factor: 3.143

9.  Successful continuation of pregnancy in a patient with COVID-19-related ARDS.

Authors:  Didier Dreyfuss; Jeanne Sibiude; Laura Federici; Olivier Picone
Journal:  BMJ Case Rep       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.